Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack
K-Number: K163085 · 2017-02-14
Device Summary
Frequently Asked Questions
What is the Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?
Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack is a medical device that received FDA 510(k) clearance on 2017-02-14. The listed applicant is Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC. The 510(k) number is K163085.
When did Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack receive FDA 510(k) clearance?
Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack received FDA 510(k) clearance on 2017-02-14, under 510(k) number K163085.
Who is the listed applicant for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?
The FDA 510(k) record lists Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack?
The FDA product code for Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack is OZN.
Related Devices (Code: OZN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.